Paper41585201
Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation.
Yang CH and 10 others. J Dent Sci, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation. Papers, record 41585201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41585201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27288358 | A Minimal DNA Methylation Signature in Oral Tongue Squamous Cell Carcinoma Links Altered Methylation with Tumor Attributes. | Mol Cancer Res | 2016 | https://conductscience.org/library/papers/27288358 | PubMed |
| 2 | 34278794 | AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. | J Chem Inf Model | 2021 | https://conductscience.org/library/papers/34278794 | PubMed |
| 3 | 31596908 | Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma. | PLoS One | 2019 | https://conductscience.org/library/papers/31596908 | PubMed |
| 4 | 36304286 | Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer. | Front Bioinform | 2022 | https://conductscience.org/library/papers/36304286 | PubMed |
| 5 | 29788355 | SWISS-MODEL: homology modelling of protein structures and complexes. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29788355 | PubMed |
| 6 | 33628624 | Activin A backs-up TGF-ß to promote regulatory T cells. | Oncoimmunology | 2021 | https://conductscience.org/library/papers/33628624 | PubMed |
| 7 | 34977258 | Higher Expression of SPP1 Predicts Poorer Survival Outcomes in Head and Neck Cancer. | J Immunol Res | 2021 | https://conductscience.org/library/papers/34977258 | PubMed |
| 8 | 16482217 | Structural basis for the inhibition of activin signalling by follistatin. | EMBO J | 2006 | https://conductscience.org/library/papers/16482217 | PubMed |
| 9 | 32442275 | TIMER2.0 for analysis of tumor-infiltrating immune cells. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/32442275 | PubMed |
| 10 | 32843638 | The updated landscape of tumor microenvironment and drug repurposing. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32843638 | PubMed |
| 11 | 25631445 | Comprehensive genomic characterization of head and neck squamous cell carcinomas. | Nature | 2015 | https://conductscience.org/library/papers/25631445 | PubMed |
| 12 | 32093572 | Impact of Time to Diagnosis and Treatment in Head and Neck Cancer: A Systematic Review. | Otolaryngol Head Neck Surg | 2020 | https://conductscience.org/library/papers/32093572 | PubMed |
| 13 | 36800999 | Spatial profiling technologies illuminate the tumor microenvironment. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36800999 | PubMed |
| 14 | 39552041 | UniProt: the Universal Protein Knowledgebase in 2025. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/39552041 | PubMed |
| 15 | 25176396 | jvenn: an interactive Venn diagram viewer. | BMC Bioinformatics | 2014 | https://conductscience.org/library/papers/25176396 | PubMed |
| 16 | 28241877 | Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways. | J Hematol Oncol | 2017 | https://conductscience.org/library/papers/28241877 | PubMed |
| 17 | 22072328 | Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers. | Genes Chromosomes Cancer | 2012 | https://conductscience.org/library/papers/22072328 | PubMed |
| 18 | 21989116 | A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence. | BMC Cancer | 2011 | https://conductscience.org/library/papers/21989116 | PubMed |
| 19 | 31114875 | GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/31114875 | PubMed |
| 20 | 32573845 | Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32573845 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42380705 | Can artificial intelligence diagnose the invisible? A scenario-based evaluation of AI performance in cracked tooth diagnosis. | Odontology | 2026 | https://conductscience.org/library/papers/42380705 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41585201
GET https://conductscience.org/api/papers/v1/41585201/references?page=2